January 20-21, 2026, 11:00 AM PST | 2:00 PM EST
As the demand for therapeutic synthetic peptides—such as GLP-1 receptor agonists—continues to surge, biopharmaceutical manufacturers are under increasing pressure to scale production efficiently while maintaining rigorous quality standards. This webinar brings together two innovative solutions that address critical challenges in raw material verification and peptide stability assessment.
In the first presentation, "Rapid Raw Material ID – From Pallet to Production 50% Faster," discover how the Agilent Vaya Raman system, powered by patented SORS technology, enables fast, non-invasive raw material identification through a wide range of container types. Learn how this technology streamlines sampling workflows and supports the growing needs of synthetic peptide manufacturing.
The second presentation, "Unlocking Peptide Insights: Advanced Stability Assessment with UV-Visible Second-Derivative Spectroscopy," explores how the Agilent Cary 3500 UV-Vis Spectrophotometer enhances peptide characterization. By leveraging second-derivative spectroscopy, this approach improves resolution and sensitivity, enabling more accurate monitoring of peptide therapeutic stability.
Join us to explore how these cutting-edge tools can help you accelerate workflows, ensure product quality, and gain deeper insights into complex peptide drug products.
Key learning objectives:
Who should attend:
Offered Free by: Agilent | American Pharmaceutical Review | Labcompare
See All Resources from: Agilent | American Pharmaceutical Review | Labcompare





